Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer

This publication has 25 references indexed in Scilit:

• The NCI60 human tumour cell line anticancer drug screen
  Nature Reviews Cancer, 2006
• Proteomic analysis of fast and slow muscles from normal and kyphoscoliotic mice using protein arrays, 2-DE and MS
  Proteomics, 2006
• Mass spectrometry-based proteomics
  Nature, 2003
• One‐thousand‐and‐one substrates of protein kinase CK2?
  The FASEB Journal, 2003
• β₂-Adrenergic Receptor Stimulated, G Protein-Coupled Receptor Kinase 2 Mediated, Phosphorylation of Ribosomal Protein P2
  Biochemistry, 2002
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
  Nature Reviews Cancer, 2002
• Specificity and mechanism of action of some commonly used protein kinase inhibitors
  Biochemical Journal, 2000
• Proteins P1, P2, and P0, components of the eukaryotic ribosome stalk. New structural and functional aspects
  Biochemistry and Cell Biology, 1995
• The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs
  Biochemical and Biophysical Research Communications, 1992
• Regulation of 40S ribosomal protein S6 phosphorylation in Swiss mouse 3T3 cells
  Cell, 1980